Generate Biomedicines
Clinical trials sponsored by Generate Biomedicines, explained in plain language.
-
New shot every 6 months could tame severe asthma Flare-Ups
Disease control Recruiting nowThis study tests an experimental drug called GB-0895 in about 786 adults and teens (ages 12-80) with severe asthma that isn't controlled by standard inhalers and other medications. Participants will receive either GB-0895 or a placebo as a shot every 6 months for a year. The goal…
Phase: PHASE3 • Sponsor: Generate Biomedicines • Aim: Disease control
Last updated May 17, 2026 07:50 UTC
-
New shot every 6 months could slash severe asthma attacks
Disease control Recruiting nowThis study tests a new drug called GB-0895 for people aged 12 to 80 with severe asthma that is not controlled by standard inhalers and other medications. Participants will receive either GB-0895 or a placebo injection every 6 months for a year. The main goal is to see if GB-0895 …
Phase: PHASE3 • Sponsor: Generate Biomedicines • Aim: Disease control
Last updated May 14, 2026 12:01 UTC
-
New drug aims to tame chemo side effects in bladder cancer trial
Symptom relief Recruiting nowThis early-stage study tests an experimental drug called GB-4362 given alongside two standard cancer treatments for advanced bladder cancer. The goal is to see if GB-4362 is safe and can reduce nerve damage and other side effects caused by the chemotherapy. About 37 adults with a…
Phase: PHASE1 • Sponsor: Generate Biomedicines • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC